Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Adverse effects of short-term, very-low-salt diets in subjects with risk-factor clustering.
Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients.
Amino acids in storage solution predict primary nonfunction in fatty liver grafts.
Reperfusion injury after liver preservation for transplantation.
Kallistatin is a potent new vasodilator.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Kallistatin is a potent new vasodilator.
Kallistatin is a potent new vasodilator. J Clin Invest. 1997 Jul 01; 100(1):11-7.
View in:
PubMed
subject areas
Adrenergic beta-Antagonists
Animals
Aorta, Thoracic
Blood Pressure
Bradykinin
Carrier Proteins
Humans
In Vitro Techniques
Infusions, Intravenous
Injections, Intravenous
Kallikreins
Kinins
Male
Membrane Proteins
Muscle Contraction
Muscle, Smooth, Vascular
NG-Nitroarginine Methyl Ester
Rats
Rats, Inbred BN
Rats, Inbred Strains
Rats, Inbred WKY
Rats, Sprague-Dawley
Renal Circulation
Serpins
Vasodilation
Vasodilator Agents
authors with profiles
Lee Chao
Julie Chao